Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil combined with remimazolam for non-intubated general anesthesia during bronchoscopy
ChiCTR2400094720Phase 4Not yet recruiting
- Sponsor
- Weifang Second People's Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil, remimazolam and fentanyl in Diseases requiring bronchoscopy (4 arms), sponsored by Weifang Second People's Hospital. Primary endpoints: Consciousness index, Pain index and 2 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
alfentanilremimazolamfentanyl
03
Conditions
Diseases requiring bronchoscopy
Beyond the preview
Go deeper on ChiCTR2400094720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094720.